Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22Uterine Cervical Neoplasms 4Melanoma 4Endometrial Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 3Vulvar Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Neoplasm Metastasis 2Mouth Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Rectal Neoplasms 1Prostatic Neoplasms 1Pediatric Patients With Solid Tumors 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Micrometastasis 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fallopian Tube Neoplasms 1Eyelid Sebaceous Gland Carcinoma 1

Interventions

Technetium Tc 99m Sulfur Colloid 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Eyelid Sebaceous Gland Carcinoma × Sentinel Lymph Node Biopsy × Clear all
NCT00832429 2025-07-04

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

M.D. Anderson Cancer Center

Phase 2 Completed
20 enrolled 6 charts

Eyelid Sebaceous Gland Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡